Canada Life’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Hold |
27,018
| – | – | ﹤0.01% | 1238 |
|
|
2025
Q4 | $2.17M | Sell |
27,018
-8,420
| -24% | -$566K | ﹤0.01% | 1130 |
|
|
2025
Q3 | $1.71M | Buy |
35,438
+1,266
| +4% | +$78.4K | ﹤0.01% | 1287 |
|
|
2025
Q2 | $2.55M | Buy |
34,172
+2,987
| +10% | +$198K | ﹤0.01% | 1096 |
|
|
2025
Q1 | $1.98M | Sell |
31,185
-14,577
| -32% | -$991K | ﹤0.01% | 1192 |
|
|
2024
Q4 | $3.57M | Hold |
45,762
| – | – | 0.01% | 1002 |
|
|
2024
Q3 | $3.68M | Sell |
45,762
-712
| -2% | -$57.5K | 0.01% | 1026 |
|
|
2024
Q2 | $3.85M | Sell |
46,474
-4,254
| -8% | -$374K | 0.01% | 964 |
|
|
2024
Q1 | $4.33M | Buy |
50,728
+5,933
| +13% | +$466K | 0.01% | 874 |
|
|
2023
Q4 | $3.82M | Buy |
44,795
+4,795
| +12% | +$415K | 0.01% | 907 |
|
|
2023
Q3 | $3.58M | Buy |
40,000
+3,117
| +8% | +$278K | 0.01% | 894 |
|
|
2023
Q2 | $3.14M | Sell |
36,883
-3,607
| -9% | -$305K | 0.01% | 954 |
|
|
2023
Q1 | $3.35M | Sell |
40,490
-1,144
| -3% | -$92.6K | 0.01% | 963 |
|
|
2022
Q4 | $3.28M | Buy |
41,634
+6,432
| +18% | +$517K | 0.01% | 973 |
|
|
2022
Q3 | $2.61M | Buy |
35,202
+3,979
| +13% | +$286K | 0.01% | 1024 |
|
|
2022
Q2 | $2.03M | Buy |
31,223
+3,337
| +12% | +$197K | 0.01% | 1149 |
|
|
2022
Q1 | $1.81M | Buy |
27,886
+2,018
| +8% | +$110K | ﹤0.01% | 1253 |
|
|
2021
Q4 | $1.37M | Buy |
25,868
+1,946
| +8% | +$119K | ﹤0.01% | 1391 |
|
|
2021
Q3 | $1.7M | Buy |
23,922
+4,619
| +24% | +$291K | ﹤0.01% | 1273 |
|
|
2021
Q2 | $1.29M | Sell |
19,303
-404
| -2% | -$28.6K | ﹤0.01% | 1395 |
|
|
2021
Q1 | $2.19M | Sell |
19,707
-1,535
| -7% | -$190K | 0.01% | 1087 |
|
|
2020
Q4 | $2.52M | Sell |
21,242
-2,605
| -11% | -$280K | ﹤0.01% | 1023 |
|
|
2020
Q3 | $2.08M | Sell |
23,847
-1,461
| -6% | -$128K | ﹤0.01% | 1042 |
|
|
2020
Q2 | $2.27M | Sell |
25,308
-1,118
| -4% | -$113K | 0.01% | 1008 |
|
|
2020
Q1 | $2.63M | Buy |
26,426
+1,862
| +8% | +$202K | 0.01% | 838 |
|
|
2019
Q4 | $2.8M | Buy |
+24,564
| New | +$2.97M | 0.01% | 944 |
|
|
2019
Q3 | – | Sell |
-29,453
| Closed | -$3.54M | – | 1612 |
|
|
2019
Q2 | $3.54M | Sell |
29,453
-2,259
| -7% | -$222K | 0.01% | 878 |
|
|
2019
Q1 | $2.77M | Sell |
31,712
-188
| -0.6% | -$17.1K | 0.01% | 864 |
|
|
2018
Q4 | $2.96M | Buy |
31,900
+1,812
| +6% | +$190K | 0.01% | 828 |
|
|
2018
Q3 | $3.45M | Sell |
30,088
-732
| -2% | -$75.8K | 0.01% | 850 |
|
|
2018
Q2 | $2.76M | Sell |
30,820
-39,471
| -56% | -$3.33M | 0.01% | 960 |
|
|
2018
Q1 | $5.14M | Buy |
70,291
+1,610
| +2% | +$110K | 0.01% | 700 |
|
|
2017
Q4 | $3.99M | Sell |
68,681
-3,508
| -5% | -$185K | 0.01% | 789 |
|
|
2017
Q3 | $3.12M | Sell |
72,189
-4,650
| -6% | -$193K | 0.01% | 886 |
|
|
2017
Q2 | $3.03M | Buy |
76,839
+3,050
| +4% | +$125K | 0.01% | 889 |
|
|
2017
Q1 | $2.99M | Buy |
73,789
+4,986
| +7% | +$195K | 0.01% | 896 |
|
|
2016
Q4 | $2.77M | Sell |
68,803
-995
| -1% | -$37.5K | 0.01% | 905 |
|
|
2016
Q3 | $2.53M | Buy |
69,798
+3,011
| +5% | +$103K | 0.01% | 924 |
|
|
2016
Q2 | $1.94M | Buy |
66,787
+60,425
| +950% | +$1.83M | 0.01% | 1041 |
|
|
2016
Q1 | $222K | Hold |
6,362
| – | – | ﹤0.01% | 1254 |
|
|
2015
Q4 | $205K | Hold |
6,362
| – | – | ﹤0.01% | 1266 |
|
|
2015
Q3 | $206K | Buy |
6,362
+2,600
| +69% | +$97.8K | ﹤0.01% | 1239 |
|
|
2015
Q2 | $155K | Hold |
3,762
| – | – | ﹤0.01% | 1530 |
|
|
2015
Q1 | $168K | Hold |
3,762
| – | – | ﹤0.01% | 1445 |
|
|
2014
Q4 | $140K | Hold |
3,762
| – | – | ﹤0.01% | 1515 |
|
|
2014
Q3 | $132K | Hold |
3,762
| – | – | ﹤0.01% | 1465 |
|
|
2014
Q2 | $132K | Hold |
3,762
| – | – | ﹤0.01% | 1383 |
|
|
2014
Q1 | $122K | Hold |
3,762
| – | – | ﹤0.01% | 1332 |
|
|
2013
Q4 | $160K | Buy |
+3,762
| New | +$155K | ﹤0.01% | 1195 |
|
Other funds holding HAE
VPM
VCM
RRAM
Canada Life's HAE Position: Q1 2026 in Review
Canada Life held its Haemonetics (HAE) position steady in Q1 2026 at 27,018 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1238.
Canada Life first reported a position in HAE in Q4 2013 and has held it in 49 quarters since. The position peaked at $5.14M in Q1 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Canada Life held 27,018 shares of Haemonetics worth $1.52M as of Q1 2026.
- Canada Life left its Haemonetics share count unchanged in Q1 2026.
- Haemonetics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1238 holding.
- Canada Life first reported a position in Haemonetics in Q4 2013 and has held it in 49 quarters since.
- Canada Life's Haemonetics position peaked at $5.14M in Q1 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.